Other authors have found that a decreased HAMP and FPN1 expression in the liver of CHC patients before the start of IFN and RBV therapy correlated with SVR after the treatment in patients of Japanese origin [38]. The gene discussed is SLC40A1; the disease is cryohydrocytosis.